Verano Holdings (VRNO) Non-Current Debt (2021 - 2026)
Verano Holdings (VRNO) reported Non-Current Debt of $384.2 million for Q1 2026, down 4.85% year-over-year from $403.8 million in Q1 2025, and down 1.95% quarter-over-quarter from $391.9 million in Q4 2025.
Verano Holdings (VRNO) Non-Current Debt (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Non-Current Debt data on file, last reported at $384.2 million in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $384.2 million, down 4.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $384.2 million (down 4.85% YoY), and the FY2025 annual result was $391.9 million, down 0.96% from the prior year.
- Non-Current Debt declined to $384.2 million in Q1 2026 per VRNO's latest filing, from $391.9 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $415.5 million in Q3 2023 and troughed at $143.7 million in Q2 2022.
- A 5-year average of $379.0 million and a median of $392.9 million in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2023 and 2026: Non-Current Debt surged 177.53% in 2023, then slipped 4.85% in 2026.
- A 5-year view of Non-Current Debt shows it stood at $388.5 million in 2022, then grew by 1.31% to $393.6 million in 2023, then increased by 0.52% to $395.7 million in 2024, then decreased by 0.96% to $391.9 million in 2025, then declined by 1.95% to $384.2 million in 2026.
- Business Quant data shows VRNO's Non-Current Debt at $384.2 million in Q1 2026, $391.9 million in Q4 2025, and $397.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn | 384.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 384.25 Mn |
| Mar 31, 2026 | 384.25 Mn |
| Dec 31, 2025 | 391.88 Mn |
| Dec 31, 2025 | 391.88 Mn |
| Sep 30, 2025 | 397.82 Mn |
| Sep 30, 2025 | 397.82 Mn |
| Jun 30, 2025 | 399.82 Mn |
| Jun 30, 2025 | 399.82 Mn |
| Mar 31, 2025 | 403.83 Mn |
| Mar 31, 2025 | 403.83 Mn |
| Dec 31, 2024 | 395.70 Mn |
| Dec 31, 2024 | 395.70 Mn |
| Sep 30, 2024 | 397.62 Mn |
| Sep 30, 2024 | 397.62 Mn |
| Jun 30, 2024 | 391.72 Mn |
| Jun 30, 2024 | 391.72 Mn |
| Mar 31, 2024 | 391.27 Mn |
| Mar 31, 2024 | 391.27 Mn |
| Dec 31, 2023 | 393.64 Mn |
| Dec 31, 2023 | 393.64 Mn |